GL1X · GenesisL1 explorer

MolNFT v1 · #105047 · protein

Crystal structure resolution of plasmodium falciparum FK506 binding domain (FKBP35) in complex with rapamycin at 1.4A resolution

4QT3 · FK506-binding protein (fkbp)-type peptidyl-propyl isomerase: “Crystal structure resolution of plasmodium falciparum FK506 binding domain (FKBP35) in complex with rapamycin…”. X-ray diffraction, 2 ligands (DTV, RAP), 1 pocket (best…

PDB
4QT3
Type
protein
Length
125 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
FK506-binding protein (fkbp)-type peptidyl-propyl isomerase
EC
5.2.1.8
UniProt
Q8I4V8
Ligands
DTV, RAP
Pockets
1 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFK506-binding protein (fkbp)-type peptidyl-propyl isomerase (EC 5.2.1.8)protein12510% helix, 38% strandQ8I4V8

Ligands and binding sites

  • DTV · (2S,3S)-1,4-dimercaptobutane-2,3-diol · ligand · chains A
  • RAP · Rapamycin immunosuppressant drug · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.370.7714empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4QT3 · Crystal structure resolution of Plasmodium falciparum FK506 binding domain (FKBP35) in… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8I4V8 · AlphaFold monomer V2.0 prediction for peptidyl-prolyl cis-trans isomerase FKBP35 (Q8I4V8) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.